The reduction of the average tumor volume was even more pronounced in sEphB4-Alb treated RT2 Dll4+/- group (approximately 90% reduction, p < 0.01) where Dll4/Notch and Ephrin-B2/EphB4 signaling were simultaneously inhibited (Figure 3A). The gene discussed is DLL4; the disease is neoplasm.